Naldemedine in Japanese patients with opioid-induced constipation and chronic noncancer pain: open-label Phase III studies

ダウンロード数 : ? 件

この文献の参照には次のURLをご利用ください : https://ir.lib.shimane-u.ac.jp/53080

言語	英語
著者	齊藤洋司 Yokota Takaaki 2 Project Management Department, Shionogi & Co., Ltd, Osaka, Japan Arai Masatsugu Business Development Department, Shionogi & Co., Ltd, Osaka, Japan Tada Yukio Biostatistics Center, Shionogi & Co., Ltd, Osaka, Japan Sumitani Masahiko Department of Pain and Palliative Medicine, The University of Tokyo Hospital, Tokyo, Japan
主題	opioids; peripherally-acting mu-opioid-receptor antagonists; patient assessment of constipation QOL; PAC-QOL; patient assessment of constipation symptoms; PAC-SYM; clinical studies; bowel function
掲載誌名	JOURNAL OF PAIN RESEARCH
巻	12
開始ページ	127
終了ページ	138
ISSN	1178-7090
発行日	2019
DOI	10.2147/JPR.S175900
PubMed ID	30613161
出版者	DOVE MEDICAL PRESS LTD
資料タイプ	学術雑誌論文
部局	医学部
備考	This study was funded by Shionogi. Interim data from this work were presented in part at the 51st Annual Meeting of the Japan Society of Pain Clinicians in Gifu, Japan, July 21, 2017. V Ruvini Jayasinghe, PhD of Oxford PharmaGenesis Inc, Newtown, PA, USA provided editorial assistance, which was funded by Shionogi & Co., Ltd, Osaka, Japan.